Frontiers in Oncology (Aug 2020)

Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients

  • Chiara Romani,
  • Chiara Romani,
  • Valentina Zizioli,
  • Marco Silvestri,
  • Marco Silvestri,
  • Laura Ardighieri,
  • Mattia Bugatti,
  • Michela Corsini,
  • Paola Todeschini,
  • Sergio Marchini,
  • Maurizio D'Incalci,
  • Laura Zanotti,
  • Antonella Ravaggi,
  • Antonella Ravaggi,
  • Antonella Ravaggi,
  • Fabio Facchetti,
  • Angela Gambino,
  • Angela Gambino,
  • Franco Odicino,
  • Franco Odicino,
  • Enrico Sartori,
  • Enrico Sartori,
  • Alessandro Davide Santin,
  • Stefania Mitola,
  • Eliana Bignotti,
  • Eliana Bignotti,
  • Stefano Calza,
  • Stefano Calza

DOI
https://doi.org/10.3389/fonc.2020.01287
Journal volume & issue
Vol. 10

Abstract

Read online

High-grade serous ovarian carcinoma (HGSOC) usually spreads directly into the peritoneal cavity following a transcoelomic dissemination route, although distant hematogenous metastasis exist and have been reported. However, no tumor markers can currently predict the risk of distant metastases in HGSOC. Claudins, belonging to tight-junction proteins, are dysregulated in HGSOC and functionally related to cancer progression. Here we analyzed claudin-3, -4, and -7 expression as potential markers of distant metastases. Using quantitative RT-PCR and immunohistochemistry we assessed the expression of claudins in primary HGSOC tissues, normal ovarian, and normal fallopian tube epithelia and correlated it with clinicopathological features, including the site of metastasis and the route of dissemination. Gene set enrichment analysis was performed on microarray-generated gene expression data to investigate key pathways in patients with distant metastases. We found the overall expression level of claudin-3, -4, and -7 mRNA decreased in HGSOC compared to normal tubal epithelium, currently considered the potential site of origin of many HGSOC. The reduced expression of claudin-7 is significantly associated with the development of distant metastases (p = 0.016), mainly by hematogenous route (p = 0.025). In patients with diminished expression of claudin-7, immunohistochemical staining revealed a heterogeneous pattern of membranous staining with discontinuous expression of claudin-7 along the cell border, indicative of a dischoesive architecture. The estimated reduction in the probability of distant disease is of 39% per unit increase in the level of claudin-7 (p = 0.03). Genes involved in epithelial to mesenchymal transition, hypoxia, and angiogenesis processes resulted strongly associated to hematogenous recurrence. Our data suggest a potential role of claudin-7 in discriminating distant metastatic events in HGSOC patients. The quantification of its expression levels could be a useful tool to identify patient deserving a personalized follow-up in terms of clinical and radiological assessment.

Keywords